Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FW3DQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $102,445
Award facts
- Contract value 100% obligated
- $102,444.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $102,444.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 mL formulation on August 6, 2025, with completion scheduled for August 7, 2025. This non-set-aside award was competitively procured and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, and this procurement reflects the Defense Health Agency's ongoing need to maintain adequate supplies of specialty pharmaceuticals for military beneficiaries. AmerisourceBergen's IDC with DLA represents a comprehensive pharmaceutical support vehicle that serves as a critical source for brand-name and generic medications across multiple therapeutic domains for military and veteran healthcare systems, including the U.S. Coast Guard and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FW3DQ?
SPE2DB25FW3DQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FW3DQ worth?
The government has obligated $102,445 on SPE2DB25FW3DQ.
Is contract SPE2DB25FW3DQ an order under another contract?
Yes. SPE2DB25FW3DQ is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW3DQ competed?
The extent of competition for SPE2DB25FW3DQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award